Concepedia

Shenjun Li

SL

Statistics

Publications

9

Citations

178

H-Index

9

Active since

1994

Affiliations

Binzhou Medical University(Current)

Binzhou University

Yantai University

Tongji University

Chinese Academy of Sciences

Shenjun Li is an author at Binzhou Medical University specializing in pharmacy, antibody conjugates, and antibody-drug conjugate therapy.

ORCID

Publications per year

1994–2021

9

Publications

9

Preclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE

Jing Jiang, Shenjun Li, Xiaolei Shan et al. · Toxicology Letters · 2019 · 45 citations

, , +12

HER2-targeted antibody drug conjugates for ovarian cancer therapy

Jing Jiang, Lihou Dong, Lei Wang et al. · European Journal of Pharmaceutical Sciences · 2016 · 40 citations

, , +14

Pharmacology study of a chimeric decoy receptor trap fusion protein on retina neovascularization by dual blockage of VEGF and FGF-2

Jing Jiang, Ke Xu, Ling Wang et al. · European Journal of Pharmaceutical Sciences · 2018 · 19 citations

, , +14

Study on toxicity of danshensu in beagle dogs after 3-month continuous intravenous infusion

Guisheng Li, Yonglin Gao, Shenjun Li et al. · Toxicology Mechanisms and Methods · 2009 · 15 citations

, , +14

Preclinical safety profile of RC88-ADC：a novel mesothelin-targeted antibody conjugated with Monomethyl auristatin E

Jing Jiang, Shenjun Li, Shenjun Li et al. · Drug and Chemical Toxicology · 2021 · 13 citations · Full text

, , +17

1–5 of 9